INTRODUCTION
AMP deaminase (EC 3.5.4.6), the enzyme catalysing the irreversible hydrolytic deamination of AMP to IMP and ammonia, is widely distributed among mammalian cell types. In skeletal muscle, the activity of the enzyme is much higher than in other tissues [1] , and it is well established that the ammonia produced by working muscle arises from AMP deamination [2] .
Although the physiological function of AMP deaminase is not yet fully understood, it appears to play a role in regulation of relative concentrations of intracellular purine nucleotide pools [3] , the stabilization of adenylate energy charge [4] , the replenishment of citric acid cycle intermediates [5] and the deamination of amino acids via the purine nucleotide cycle [6] .
AMP deaminase from different sources varies in qualitative and quantitative aspects of interaction with modifiers, with each form of the enzyme exhibiting properties representative of an allosteric system. Thus far, the enzyme has been studied most thoroughly in rabbit [7] [8] [9] [10] and rat [11] [12] [13] [14] skeletal muscle.
At least three isoforms of AMP deaminase have been identified in rat tissues on the basis of immunological, physical and kinetic properties [15, 16] . Isoform A is expressed in skeletal muscle and diaphragm, isoform B in kidney, and isoform C in heart muscle. On the basis of these same criteria, four AMP deaminase isoforms, El, E2, L and M, found in erythrocytes, liver and skeletal muscle respectively, have been reported to exist in various human tissues [17] . Isoform El has been found to be immunologically similar to isoform E2. Isoforms El, M and L were immunologically different from one another, but they were similar in this respect to rat isoforms C, A and B respectively.
The total amount of AMP deaminase in skeletal muscle varies distinctly during the course of animal development [18, 19] , and the observed changes in the properties of the enzyme [19, 20] suggest that a developmental shift in the muscle isoenzyme pattern may occur.
Here we describe the kinetic and regulatory properties of two developmental isoforms of AMP deaminase which have been recently reported [21] to exist in skeletal muscle of the human fetus.
MATERIALS AND METHODS Isolation of the enzyme
Samples of human fetus leg muscle at 11 and 16 weeks of gestation were obtained from the Obstetrics and Gynaecological Department of the Medical School in Gdainsk. Adult human thigh-muscle samples were obtained from the City Hospital in Starogard Gdainski. All fetal specimens were processed within 2-4 h, whereas the adult human muscle samples, taken in the course of surgery, were frozen and processed after several days. After removal of the skin and connective tissue, samples (weighing 3-8 g) were washed, homogenized in 15-20 vol. (v/w) of extraction buffer [9] , and AMP deaminase was isolated by chromatography on phosphocellulose, by the procedure of Smiley et al. [9] . The enzyme adsorbed on phosphocellulose was eluted stepwise, by washing the column with 0.75 M-KCl and then 2.0 MKCl. The AMP deaminase in extracts obtained from both fetus and adult human skeletal muscle was eluted from the column in two well-separated peaks of activity [21] , indicating the presence of at least two different molecular forms of the enzyme. In 11-week-old fetal muscle, most of the AMP deaminase activity was eluted with 2.0 M-KCI ('fetal' isoform) whereas in 16-week-old fetal tissue most of the enzyme activity was eluted with 0.75 M-KCI ('adult' isoform). In adult human skeletal muscle, almost all AMP deaminase activity was eluted with 0.75 M-KC1; the 'fetal' isoform constituted only a very small part of total enzyme activity in that tissue. The specific activity of the preparation obtained (measured at 10 mM-AMP and 30°C) was 1.3 +0.3 and 17.4 + 1.2 ,mol/min per mg of protein for 'adult' and 'fetal' isoforms of 11-week-old fetal muscle enzyme respectively (n = 5), 6.2 +0.5 and 7.1 +0.7jtmol/min per mg for 'adult' and 'fetal' isoforms of 16-week-old fetal muscle enzyme respectively (n = 3), and 31.2 + 4.2 ,umol/min per mg for 'adult' isoform obtained from adult human skeletal-muscle extract (n = 3). The appropriate relative activities of the two AMP deaminase isoforms (the ratio of the specific activity of the 'fetal' isoform to that of the 'adult' one) were about 13 and 1 for the enzyme from 1 1-and 16-week-old skeletal muscle respectively. Enzyme assay AMP deaminase activity was measured colorimetrically by the phenol/hypochlorite method of Chaney & Marbach [22] . The incubation medium, in a final volume of 0.5 ml, contained 0.05 M-potassium succinate buffer, pH 6.5, 100 mM-KCl and various concentrations of the substrate and effectors. After equilibration of the medium at 30°C, 25 ,l of enzyme solution was added to start the reaction. The initial velocity of the reaction was determined from the mean amount of ammonia liberated in three parallel incubations. No symptoms of enzyme denaturation was observed, as judged from the proportionality of the ammonia liberation versus time for the period of the reaction course (15 min).
When 'adult' isoforms of 16-week-old fetus and adult human enzyme were examined at low (75 gM) substrate concentration, the spectrophotometric method [23] was used to monitor enzyme activity. The decrease in A265 for 2 min was monitored with a Specord UV-vis spectrophotometer fitted with a constant-temperature cell housing. From a 2 min tracing of the A265 change, the initial velocity of the reaction was calculated by using the molar coefficient given by Smiley & Suelter [8] . The reaction mixture, in a final volume of 3 ml, contained 0.05 M-potassium succinate buffer, pH 6.5, 100 mM-KCl, 75/tM-AMP and different concentrations of various effectors. After equilibration at 30°C, 25 ,u1 of enzyme solution was added to the incubation medium to start the reaction. The measurements were carried out against a blank containing all the additions except substrate.
Protein was determined with Coomasie Brillant Blue [24] .
Calculation of kinetic parameters
The kinetic parameters of the reaction (maximum velocity of the reaction, V..ax, half-saturation constant, so5, and co-operativity coefficient, h) were calculated on a microcomputer, by using a BASIC program based on the flow diagram described by Atkins [25] . The fundamental part of this program is a subroutine which performs a series of iterative regression steps for a given preliminary value of kmax. In the course of these iterations, the logarithmic form of the Hill equation was fitted directly to the experimental kinetic data by minimizing the sum of the squares of residuals. Reagents 5'-AMP (type V, from horse skeletal muscle), ADP, ATP (Na+ salts) and GTP (Li' salt) were supplied by Sigma (St. Louis, MO, U.S.A.); CoA (Li' salt) and activated fatty acids were purchased from CalbiochemBoehringer (La Jolla, CA, U.S.A.); cellulose phosphate was from Whatman (Maidstone, Kent, U.K.). All other chemicals were from Polskie Odczynniki Chemiczne (Gliwice, Poland).
RESULTS
The two molecular forms of AMP deaminase obtained from 11-week-old human fetal muscle possessed distinctly different kinetic and regulatory properties. In the presence of 100 mM-KCl and no nucleotide effectors (control conditions), the reaction catalysed by 'adult' isoform showed hyperbolic-type kinetics (h = 1.1), reaching saturation velocity at about 3 mM-AMP. Under the same conditions, the 'fetal' isoform needed nearly 5 times higher substrate concentration to reach its saturation velocity. This same difference had been calculated for half-saturation constants (Table 1) .
For both isoforms, the addition of 1 mM-ATP stimulated the reaction at lower substrate concentrations, and inhibited at higher ones. The stimulatory effect was much more pronounced, however, for the 'fetal' isoform. In 11-week-old fetal muscle, 1 mM-ATP decreased the s05 value of the 'adult' isoform nearly 2-fold, but caused a 4.5-fold decrease in the 'fetal' one (Table 1) . ADP (1 mM) decreased the so05 value for the 'adult' isoform 2-fold and that for the 'fetal' isoform 3-fold. In addition to enhancing the enzyme-substrate affinity, ADP at higher concentrations distinctly decreased the maximum velocity of the reaction of both molecular forms of AMP deaminase. P1 inhibited the activity of 11-week-old human fetal muscle AMP deaminase isoforms at each substrate concentration tested, mainly by influencing the maximum velocity of the reaction (Table 1) . Fig. 1(a) shows the substrate-saturation curves for the reaction catalysed by 'adult' isoform of 16-week-old human fetal muscle AMP deaminase. In the presence of 100 mM-KCl this isoform followed regular hyperbolic kinetics (h = 1.1), as it did in 11-week-old muscle. Unlike the enzyme isolated from 11-week-old fetal muscle, however, the 'adult' isoform from 16-week-old muscle was only minimally affected by 1 mM-ATP (Table 2 ); 1 mM-ADP halved its half-saturation constant (from 0.5 to 0.25 mM), whereas 2.5 mM-P1 more than doubled it (to 1.09 mM). Neither, however, had any effect on the maximum velocity of the reaction ( Table 2) . shown) are consistent with this hypothesis and demonstrate clearly the two-component character of these curves. Hence, each of the velocity curves in Fig. I(b) represents the activity, which is the sum of the activities of two co-existing kinetically different subforms of AMP deaminase. In contrast with the sub-form operating with full activity in the lower range of substrate concentrations, the second one seems to be a regulatory protein, and under control conditions it exhibits a sigmoidal substrate-saturation profile. Addition of 2.5 mM-P1 to the incubation medium strongly inhibited the activity of 'fetal' isoform of AMP deaminase from skeletal muscle of 16-week-old human fetus at each substrate concentration tested. In the presence of this inhibitor the two-component character of the kinetic curve is even more visible, and the inflection point, which under control conditions occurred at about 2 mM-AMP, is now located at about 9 mm concentration of substrate (Fig. lb) . ATP (1 mM) strongly activated the 'fetal' isoform of 16-week-old fetal muscle AMP deaminase over the whole range of substrate concentrations examined. Interestingly, the distribution of experimental data points in the presence of this nucleotide was nearly regular, and the inflection point was hardly detectable. The same seems to be true when 1 mM-ADP was added to the reaction mixture. In contrast with ATP, however, ADP did not change the maximum velocity of the reaction (Fig. lb) . Table 2 presents the kinetic parameters calculated for the reaction catalysed by the 'fetal' isoform of AMP deaminase from the skeletal muscle of 16-week-old human fetus in the absence and in the presence of the effectors tested. Under control conditions, as well as for the reaction examined in the presence of 2.5 mM-Pi, the appropriate values of sO 5and h and the relative values of the maximum velocity of the reaction were calculated for both components of the biphasic velocity curves.
In the presence of 100 mM-KCl only, the reaction catalysed by adult human skeletal-muscle AMP deaminase revealed a regular hyperbolic type of kinetics, with the s50 value as low as 0.65 mm ( Table 3 ). The addition of 1 mM-ADP to the incubation medium had no effect on the enzyme activity, whereas addition of 1 mm-ATP or 2.5 mM-Pi slightly inhibited the activity of the enzyme, affecting s0.5, but not Vnax. or h.
The effect of some important regulatory ligands on AMP deaminase activity from 16-week-old fetal muscle is shown in Figs. 2(a) and 3(a) . Both molecular forms of fetal muscle AMP deaminase exhibited qualitatively and quantitatively different properties in the presence of these ligands. ATP strongly stimulated the 'fetal' isoform of 16-week-old fetal muscle enzyme, but had the opposite effect on the activity of the 'adult' isoform. In contrast, ADP activated and GTP and Pi inhibited the activity of both isoforms extracted from 16-week-old human fetal muscle. Interestingly, the inhibition of the 'fetal' isoformby GTP decreased with effector concenrtrations higher than 0.1 mm. At adenylate concentrations as low as 75/M (Fig. 3a) , however, no activation by ADP (at least adult human muscle enzyme (Fig. 2b) at concentrations as low as 50 ,uM, i.e. much lower than has been found for the 'adult' isoform of fetal muscle AMP deaminase (Fig.  2a) . Nevertheless, in the presence of very low concentrations of adenylate, the activation by ADP was hardly detectable for effector concentrations up to 25,M (Fig. 3b) . Table 4 presents the effect of CoA and CoA derivatives of short-and long-chain fatty acids on the activity of molecular forms of skeletal-muscle AMP deaminase. The modulatory effect exerted by the activated fatty acids tested was found to be dependent not only on the chemical nature and concentration of the effector, but also on the substrate concentration. Activated longchain fatty acids inhibited the 'adult' isoform of AMP deaminase extracted from 11-and 16-week-old human fetal muscle and from adult human skeletal muscle. At 75 /SM substrate (see Fig. 3 ), the strong inhibition, even at very low concentrations of activated fatty acids, was especially distinct for adult human skeletal-muscle enzyme.
The two isoforms of 11-and 16-week-old human fetal skeletal-muscle AMP-deaminase have been found (results not shown) to be different with respect to their pHdependent activity modulation. The enzyme extracted from less mature fetal tissue (especially its 'fetal' isoform) showed a marked decrease in the activity at the acidic side of the pH optimum (pH 6.6 for 'adult' isoform and 6.8 for 'fetal' isoform). The decrease in enzyme activity at the alkaline side of the optimum was much less pronounced. In contrast with that, the AMP deaminase extracted from 16-week-old human fetal skeletal muscle showed a more marked decrease in the activity at the alkaline side of its optimum (pH 6.4 for both isoforms). Again, the 'fetal' isoform of the enzyme was found to be more sensitive to pH-induced activity modulation. AMP deaminase from adult human tissue had a pH/activity profile similar to that of the 'adult' isoform of 16-weekold fetal skeletal muscle.
DISCUSSION
We previously reported [19] that AMP deaminase from 14-day-old chick-embryo skeletal muscle changed its catalytic properties differently from the enzyme from adult animal tissue in response to temperature. We hypothesized that different catalytic properties of AMP deaminase in the tissues studied reflected a different isoenzyme composition in developing chick muscle. In 1978, Sammons & Chilson [20] presented data demonstrating the occurrence of an isoenzyme change during the development of chick skeletal muscle. Subsequent studies performed in our laboratory [26] [27] [28] showed that the enzyme obtained from 14-day-old chick embryo differed in many kinetic and regulatory properties from that obtained from adult hen muscle.
The existence of a developmental shift of AMP deaminase isoenzyme composition in several rat tissues was first reported by Ogasawara et al. [29] . They concluded that skeletal muscle, in contrast with heart and liver, contained mostly the isoenzyme A form of AMP deaminase throughout postnatal animal development, but that the skeletal muscle of 3-day-old rat transiently contained another isoenzyme. Thus an isoenzyme composition change might also occur in rat muscle tissue. This hypothesis might be consistent with the different catalytic response to temperature which has been found in skeletal-muscle extracts of newborn and older rats [30] . Most recently, Marquetant et al. [31] have demonstrated that there are three developmental isoforms of rat skeletal-muscle AMP deaminase, which are presumably the result of developmentally controlled changes in gene expression.
AMP deaminase from human skeletal muscle was first
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The activity measured under control conditions is set at 100. The enzyme activity was measured at 0.3 mm-and 0.6 mM-AMP when 'adult' and 'fetal' isoforms were studied respectively. ratios, which in control conditions were 12.2 and 1.4 (i.e. 8.8:1), for low-so5 and high-s05 components of the totalvelocity curve respectively, in the presence of 2.5 mM-Pi changed to 5.9 and 0.16 (i.e. 35 .9: 1) for low-so5 and highs05 components of the total velocity curve respectively. This change made the inflection in the total-velocity curve (Fig. lb) even more distinct than that in the curve obtained for control conditions. ATP and ADP acted in an opposite way to Pi: in the presence of these effectors the inflection in the total-velocity curve (Fig. lb) was hardly detectable.
It has been postulated by Marquetant et al. [31] that three developmental isoforms, produced sequentially during ontogenesis in rat skeletal muscle, indicate the existence of a developmentally controlled schedule of AMP deaminase gene expression. The same appears to be true for human muscle AMP deaminase.
In our previous paper we postulated [21] that patients with myoadenylate deaminase deficiency [38, 39] probably have no 'adult' isoform in their muscle tissue, and that the remnant activities found in the muscle biopsies of the patients with this deficiency would consist of the 'fetal' isoform only. The cloning of skeletal-muscle AMP deaminase gene [40] may be very helpful in searching for the molecular basis of the myoadenylate deficiency syndrome.
